Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Journal of Internal Medicine|May 2, 2024
Epigenetic reprograming in myalgic encephalomyelitis/chronic fatigue syndrome: A narrative of latent virusesEirini Apostolou, Anders Rosén
Clinical and Experimental Rheumatology|September 8, 2020
Type-III interferons in Sjögren's syndromeEirini Apostolou, Athanasios G Tzioufas
Frontiers in Immunology|April 11, 2019
Ablation of the Chaperone Protein ERdj5 Results in a Sjögren's Syndrome-Like Phenotype in Mice, Consistent With an Upregulated Unfolded Protein Response in Human PatientsEirini Apostolou, Petros Moustardas, Takao Iwawaki, et al.
Clinical Epigenetics|December 14, 2022
Defining post-acute COVID-19 syndrome (PACS) by an epigenetic biosignature in peripheral blood mononuclear cellsFrida Nikesjö, Shumaila Sayyab, Lovisa Karlsson, et al.
Seminars in Immunopathology|February 7, 2013
Activin, neutrophils, and inflammation: just coincidence?Paschalis Sideras, Eirini Apostolou, Athanasios Stavropoulos, et al.
Frontiers in Medicine|April 17, 2020
Metabolic Dysfunction in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Not Due to Anti-mitochondrial AntibodiesIsabell Nilsson, Jeremy Palmer, Eirini Apostolou, et al.
Frontiers in Immunology|July 26, 2021
Deregulation of the Kallikrein Protease Family in the Salivary Glands of the Sjögren's Syndrome ERdj5 Knockout Mouse ModelPetros Moustardas, Naomi Yamada-Fowler, Eirini Apostolou, et al.
Frontiers in Medicine|July 17, 2023
Post-COVID sequelae effect in chronic fatigue syndrome: SARS-CoV-2 triggers latent adenovirus in the oral mucosaUlf Hannestad, Eirini Apostolou, Per Sjögren, et al.
Frontiers in Immunology|November 7, 2022
Saliva antibody-fingerprint of reactivated latent viruses after mild/asymptomatic COVID-19 is unique in patients with myalgic-encephalomyelitis/chronic fatigue syndromeEirini Apostolou, Muhammad Rizwan, Petros Moustardas, et al.
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]|February 10, 2016
TGF-β signaling is activated in patients with chronic HBV infection and repressed by SMAD7 overexpression after successful antiviral treatmentNikoletta Argentou, Georgios Germanidis, Prodromos Hytiroglou, et al.
Pageof 2